Outcomes with first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) vs physician's choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2-advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial

El Saghir N. S., Yap Y. S., Eralp Y., Im S., Azim H. A., Rihani J., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.16_SUPPL, ss.1063, 2023 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 41 Sayı: 16_SUPPL
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1200/jco.2023.41.16_suppl.1063
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
  • Sayfa Sayıları: ss.1063
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır